IMCRImmunocore Holdings plc
$29.39-9.8% 1Y
$29.39
$27.7952 weeks$40.22
Is the price fair?
What IMCR's price assumes
Immunocore Holdings plc did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.61× revenue.
3.61
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.71
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 3.71
- EV / EBIToperating margin −5.2%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $1.55B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.